These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12239444)

  • 1. Small cell lung cancer: defining a role for emerging platinum drugs.
    Schiller JH
    Oncology; 2002; 63(2):105-14. PubMed ID: 12239444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
    Jain N; Lam YM; Pym J; Campling BG
    Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassay.
    Sasaki Y; Shinkai T; Eguchi K; Tamura T; Ohe Y; Ohmori T; Saijo N
    Cancer Chemother Pharmacol; 1991; 27(4):263-70. PubMed ID: 1847845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of therapeutic trials of carboplatin in lung cancer.
    Bunn PA
    Semin Oncol; 1989 Apr; 16(2 Suppl 5):27-33. PubMed ID: 2541506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis.
    Genestreti G; Tiseo M; Kenmotsu H; Kazushige W; Di Battista M; Cavallo G; Carloni F; Bongiovanni A; Burgio MA; Casanova C; Metro G; Scarpi E; Korkmaz T; Selcuk S; Roopa K; Califano R
    Clin Lung Cancer; 2015 Nov; 16(6):e223-8. PubMed ID: 25983005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evidence based chemotherapy for lung cancer].
    Watanabe H; Saijo N
    Gan To Kagaku Ryoho; 2000 Jan; 27(1):30-43. PubMed ID: 10660731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of carboplatin in the treatment of small-cell lung cancer.
    Ettinger DS
    Oncology (Williston Park); 1998 Jan; 12(1 Suppl 2):36-43. PubMed ID: 9516610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of clinical trials for small cell lung cancer.
    Fischer B; Arcaro A
    Rev Recent Clin Trials; 2008 Jan; 3(1):40-61. PubMed ID: 18474014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-platinum chemotherapy combined with etoposide in metastatic brain tumor from small cell lung carcinoma.
    Yamada SM; Yamada S; Takahashi H; Teramoto A; Nakayama H
    J Neurooncol; 2005 Feb; 71(3):259-65. PubMed ID: 15735914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum combined with radiation therapy in small cell lung cancer: focusing like a laser beam on crucial issues.
    Turrisi AT
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):36-42. PubMed ID: 8052872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
    Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
    Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platinum compounds in the treatment of advanced breast cancer.
    Martín M
    Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current standards of care in small-cell and non-small-cell lung cancer.
    Schiller JH
    Oncology; 2001; 61 Suppl 1():3-13. PubMed ID: 11598409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etoposide plus ifosfamide plus cisplatin in the treatment of small cell lung cancer.
    Sandler AB
    Semin Oncol; 1998 Feb; 25(1 Suppl 2):38-41. PubMed ID: 9535210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in chemotherapy for small cell lung cancer: single-agent activity of newer agents.
    Argiris A; Murren JR
    Cancer J; 2001; 7(3):228-35. PubMed ID: 11419031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of patients with small-cell lung cancer: from meta-analyses to clinical practice.
    Rossi A; Martelli O; Di Maio M
    Cancer Treat Rev; 2013 Aug; 39(5):498-506. PubMed ID: 23084098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status and future prospects for satraplatin, an oral platinum analogue.
    Choy H; Park C; Yao M
    Clin Cancer Res; 2008 Mar; 14(6):1633-8. PubMed ID: 18347164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar chromosomal changes in cisplatin and oxaliplatin-resistant sublines of the H69 SCLC cell line are not associated with platinum resistance.
    Stordal B; Peters G; Davey R
    Genes Chromosomes Cancer; 2006 Dec; 45(12):1094-105. PubMed ID: 16967470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Picoplatin overcomes resistance to cell toxicity in small-cell lung cancer cells previously treated with cisplatin and carboplatin.
    Tang CH; Parham C; Shocron E; McMahon G; Patel N
    Cancer Chemother Pharmacol; 2011 Jun; 67(6):1389-400. PubMed ID: 20809122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experiences with carboplatin (paraplatin) in lung cancer.
    Bunn PA
    Semin Oncol; 1992 Feb; 19(1 Suppl 2):1-11. PubMed ID: 1329216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.